Rebuttal from authors re: Joaquim Bellmunt. Chemotherapy for prostate cancer in senior adults: are we treating the elderly or the frail? Eur Urol 2009;55:1310-2.
Department of Medical Oncology, Institut Bergonié, Bordeaux, France. italiano@bergonie.org
Antoine
A
Italiano
Karim
K
Fizazi
D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000187:drug effects; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage* / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000009:adverse effects; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D016330:Frail Elderly; D015577:Geriatric Assessment; D006801:Humans; D008297:Male; D018579:Patient Selection; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D018570:Risk Assessment; D016019:Survival Analysis; D016896:Treatment Outcome
D018931:Antineoplastic Agents, Hormonal